0001209191-22-008271.txt : 20220209
0001209191-22-008271.hdr.sgml : 20220209
20220209211333
ACCESSION NUMBER: 0001209191-22-008271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220209
FILED AS OF DATE: 20220209
DATE AS OF CHANGE: 20220209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farid Ramy
CENTRAL INDEX KEY: 0001797707
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 22609302
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-09
0
0001490978
Schrodinger, Inc.
SDGR
0001797707
Farid Ramy
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR
NEW YORK
NY
10036
1
1
0
0
President & CEO
Stock Option (right to buy)
27.76
2022-02-09
4
A
0
215000
0.00
A
2032-02-09
Common Stock
215000
215000
D
The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.
/s/ Donald Shum, as attorney-in-fact for Ramy Farid
2022-02-09